Susquehanna Fundamental Investments’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-50,350
Closed -$872K 1097
2024
Q4
$872K Buy
+50,350
New +$972K 0.01% 747
2024
Q2
$1.28M Sell
62,903
-9,543
-13% -$169K 0.03% 513
2024
Q1
$1.24M Buy
+72,446
New +$1.14M 0.06% 312
2021
Q4
Sell
-13,093
Closed -$363K 1488
2021
Q3
$363K Sell
13,093
-48,500
-79% -$1.48M 0.01% 1333
2021
Q2
$2.4M Sell
61,593
-17,100
-22% -$613K 0.04% 541
2021
Q1
$2.27M Sell
78,693
-17,200
-18% -$588K 0.04% 597
2020
Q4
$2.54M Buy
95,893
+13,093
+16% +$267K 0.05% 546
2020
Q3
$1.26M Buy
82,800
+1,600
+2% +$33.5K 0.04% 563
2020
Q2
$1.65M Buy
81,200
+58,000
+250% +$1.04M 0.08% 329
2020
Q1
$240K Buy
+23,200
New +$649K 0.05% 247

Other funds holding CLB

Susquehanna Fundamental Investments's CLB Position: Q1 2025 in Review

Susquehanna Fundamental Investments sold out of Core Laboratories (CLB) in Q1 2025, closing a stake of 50,350 shares — an estimated $872K sold.

Susquehanna Fundamental Investments first reported a position in CLB in Q1 2020 and held it in 10 quarters. The position peaked at $2.54M in Q4 2020. 195 funds tracked by Wall St. Rank hold CLB as of Q1 2025.

  • Susquehanna Fundamental Investments reported no remaining Core Laboratories position as of Q1 2025 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 50,350 Core Laboratories shares in Q1 2025, an estimated $872K.
  • Susquehanna Fundamental Investments first reported a position in Core Laboratories in Q1 2020 and held it in 10 quarters.
  • Susquehanna Fundamental Investments's Core Laboratories position peaked at $2.54M in Q4 2020.
  • 195 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2025.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2025, filed 14 May 2025.